Ask AI
ProCE Banner Activity

Real-world Experience With LA CAB PrEP in Women: US OPERA Cohort 

Conference Coverage
Slideset

In this descriptive report from the observational OPERA study, LA CAB PrEP was highly effective in the prevention of HIV-1 infection among cisgender and transgender women. Although 44% of women had at least 1 late injection, most injections were given on time, and most injection delays were short and did not require CAB reinitiation. 

Released: August 04, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with the International AIDS Society.

ProCE Banner

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

International AIDS Society

ProCE Banner

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions